Tear drop tests as effective as blood for diabetes testing, study finds

Share this article:
There is new hope for diabetics who dread frequent finger pricks and blood draws used to monitor their blood glucose levels. Scientists say they are developing a device that can test blood sugar levels via teardrops instead of blood.

In laboratory tests conducted on rabbits, scientists found that levels of glucose in tears track the amounts of glucose in the blood. This finding indicates it could be possible “to monitor blood glucose changes without the potential pain from the repeated invasive blood-drawing method,” said researchers, who were led by Mark Meyerhoff, Ph.D., of the University of Michigan.

Meyerhoff explained that because of the rapidly growing number of people with diabetes worldwide — currently there are 350 million diabetics — there is a need to develop more pain-free and accurate methods of checking glucose levels. Devices that offer an alternative to the hand-held meters could increase testing compliance, experts believe.

The study appears in the American Chemical Society's journal Analytical Chemistry.
Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.